NCT05166460 (QuitWIT) is a NA clinical trial of Kidney cooling device in Kidney Transplant; Complications, sponsored by Thomas Skinner.

Who is sponsoring NCT05166460?

NCT05166460 is sponsored by Thomas Skinner.

What drugs are being tested in NCT05166460?

Interventions in NCT05166460: Kidney cooling device.

What condition does NCT05166460 study?

NCT05166460 studies Kidney Transplant; Complications, Delayed Graft Function.

Is NCT05166460 still recruiting?

NCT05166460 is currently status unknown. Last updated 21 April 2023.

Last reviewed 2023-04-21 · How we verify

NCT05166460: QuitWIT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation

Status unknown NA Last updated 21 April 2023

What this trial tests

NA trial testing Kidney cooling device in Kidney Transplant; Complications in 45 participants. Status unknown.

Timeline

1 October 2023

Primary endpoint
15 January 2026

15 January 2026

Quick facts

Lead sponsor	Thomas Skinner
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	device feasibility
Enrollment	45
Start date	1 October 2023
Primary completion	15 January 2026
Estimated completion	15 January 2026
Sites	1 location across Canada

Drugs / interventions tested

Kidney cooling device

Conditions studied

Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
Delayed Graft Function — all drugs for Delayed Graft Function →

Sponsor

Thomas Skinner

Who can join

18 and older, any sex, with Kidney Transplant; Complications or Delayed Graft Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Avoiding warm ischemia time during vascular anastomosis of the renal allograft is important to prevent damage. The investigators are studying a cooling device that may control the temperature of the renal allograft during transplant surgery; attempting to keep temperatures at or below 5°C for at least 60 minutes. If found effective, this could eliminate warm ischemia and potentially prevent damage to transplanted kidneys.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Kidney Transplant; Complications

Currently open trials in the same condition.

NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT06958796 — Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) · Phase 4 · recruiting
NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
NCT07033858 — Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation · NA · recruiting
NCT05782543 — Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05166460 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thomas Skinner
Last refreshed: 21 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05166460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing